These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 36738975

  • 1. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores.
    Okubo Y, Sato S, Hasegawa C, Koizumi M, Suzuki T, Yamamoto Y, Yoshioka E, Ono K, Washimi K, Yokose T, Kishida T, Miyagi Y.
    Hum Pathol; 2023 May; 135():99-107. PubMed ID: 36738975
    [Abstract] [Full Text] [Related]

  • 2. Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy.
    Downes MR, Xu B, van der Kwast TH.
    Eur J Cancer; 2021 May; 148():432-439. PubMed ID: 33077335
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C, Downes M, Jain R, Ientilucci M, Fleshner N, Perlis N, van der Kwast T.
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [Abstract] [Full Text] [Related]

  • 4. Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.
    van der Slot MA, Seyrek N, Kweldam CF, den Bakker MA, Busstra MB, Gan M, Klaver S, Rietbergen JBW, van Leenders GJLH.
    World J Urol; 2022 Nov; 40(11):2723-2729. PubMed ID: 36190529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
    Seyrek N, Hollemans E, Osanto S, Pelger RCM, van der Poel HG, Bekers E, Bangma CH, Rietbergen J, Roobol MJ, Schoots IG, van Leenders GJLH.
    Histopathology; 2022 Feb; 80(3):558-565. PubMed ID: 34706119
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.
    Guo CC, Epstein JI.
    Mod Pathol; 2006 Dec; 19(12):1528-35. PubMed ID: 16980940
    [Abstract] [Full Text] [Related]

  • 11. Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.
    Rijstenberg LL, Hansum T, Kweldam CF, Kümmerlin IP, Remmers S, Roobol MJ, van Leenders GJLH.
    Histopathology; 2022 Jun; 80(7):1041-1049. PubMed ID: 35384019
    [Abstract] [Full Text] [Related]

  • 12. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Ishida R, Sano T, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T.
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.
    Downes MR, Liu KN, Yu Y, Lajkosz K, Kroon LJ, Hollemans E, Fleshner N, Finelli A, van Leenders GJLH, Iczkowski KA, van der Kwast TH.
    Clin Genitourin Cancer; 2024 Feb; 22(1):47-55. PubMed ID: 37558528
    [Abstract] [Full Text] [Related]

  • 15. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB, Magi-Galluzzi C, Han B, Zhou M.
    Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.
    Shah RB, Nguyen JK, Przybycin CG, Reynolds JP, Cox R, Myles J, Klein E, McKenney JK.
    Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493
    [Abstract] [Full Text] [Related]

  • 19. Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy.
    Seyrek N, Hollemans E, Andrinopoulou ER, Osanto S, Pelger RCM, van der Poel HG, Bekers E, Remmers S, Schoots IG, van Leenders GJLH.
    Virchows Arch; 2022 Jun; 480(6):1149-1157. PubMed ID: 35157140
    [Abstract] [Full Text] [Related]

  • 20. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
    Tom MC, Nguyen JK, Lucianò R, Mian OY, Stephans KL, Ciezki JP, Smile TD, Wei W, McKenney JK, Magi-Galluzzi C, Tendulkar RD.
    J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.